| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,000 | $10 | $99K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,530 | $30 | $51.9K |
| J3262 | Injection, tocilizumab, 1 mg | 9,360 | $10 | $46.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,320 | $30 | $34.3K |
| J0897 | Injection, denosumab, 1 mg | 1,440 | $20 | $25.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 130 | $90 | $11.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 120 | $50 | $6.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $110 | $6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 30 | $170 | $5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 40 | $130 | $4.7K |